Back to team page
Andrew has 10 years of experience in the medical device industry in various roles within quality assurance and regulatory affairs. During this time, he led preparation efforts for a successful first-time FDA inspection, research efforts to support 510(k) submissions, and investigation and resolution of product and process deficiencies. He also implemented statistical methods and lean tools to improve process efficiency. This experience has provided him with a unique perspective on how a quality system can be an effective tool for any company. At Bold Insight, Andrew is responsible for the development and maintenance of our quality system, ensuring the continuous improvement of our processes and the quality of service we provide our clients. Andrew holds an BS in Bioengineering from Michigan State University.
Bold facts
Learn more about
Read our team’s latest bold insights
Insights from CES 2024 highlight AI-driven changes in the automotive sales experience: customer-centric strategies, opportunities for personalization, and evolving business models reshaping the industry.
At the 2024 CES, it was clear the demand for an unparalleled in-car experience is igniting a revolution, reshaping the way humans perceive and interact with vehicles. We gathered 6 takeaways from the conference for delivering the next gen experience in auto infotainment.
A summary of the day’s research findings helps teams to stay aligned, drives report outcomes, and ensures stakeholder goals are top of mind.
Bold Insight launched a global AI study in March 2023 that included: 24 multilingual interviews conducted with UX researchers in 19 countries, spanning 22 languages. 27 interviews in English with global UX researchers representing 24 countries. Our global study led us...